12
JUL
2019

First SSc Patient Dosed with Investigational Inhibitor KD025 in Phase 2 Trial

Posted By :
Comments : Off
First SSc Patient Dosed with Investigational Inhibitor KD025 in Phase 2 Trial
Source: Scleroderma AwarePublished on 2019-07-12
About the Author